138 related articles for article (PubMed ID: 2570594)
1. C4A gene deletion: association with Graves' disease.
Ratanachaiyavong S; Lloyd L; McGregor AM
J Mol Endocrinol; 1989 Sep; 3(2):145-53. PubMed ID: 2570594
[TBL] [Abstract][Full Text] [Related]
2. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
3. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in the structural basis of the human complement C4A null allele (C4A Q0) as revealed by HindIII restriction fragment length polymorphism analysis.
Uring-Lambert B; Vegnaduzzi N; Carroll MC; Tongio MM; Goetz J; Hauptmann G
FEBS Lett; 1987 Jun; 217(1):65-8. PubMed ID: 2885219
[TBL] [Abstract][Full Text] [Related]
5. Molecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus.
Goldstein R; Arnett FC; McLean RH; Bias WB; Duvic M
Arthritis Rheum; 1988 Jun; 31(6):736-44. PubMed ID: 3260100
[TBL] [Abstract][Full Text] [Related]
6. A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis.
Briggs DC; Welsh K; Pereira RS; Black CM
Arthritis Rheum; 1986 Oct; 29(10):1274-7. PubMed ID: 3490265
[TBL] [Abstract][Full Text] [Related]
7. DNA polymorphism of major histocompatibility complex class II and class III genes in systemic lupus erythematosus.
So AK; Fielder AH; Warner CA; Isenberg DA; Batchelor JR; Walport MJ
Tissue Antigens; 1990 Mar; 35(3):144-7. PubMed ID: 1973860
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
Skanes V; Larsen B; Sampson-Murphy L; Farid NR
Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
[TBL] [Abstract][Full Text] [Related]
9. Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans.
Howard PF; Hochberg MC; Bias WB; Arnett FC; McLean RH
Am J Med; 1986 Aug; 81(2):187-93. PubMed ID: 3461713
[TBL] [Abstract][Full Text] [Related]
10. C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus.
Olsen ML; Goldstein R; Arnett FC; Duvic M; Pollack M; Reveille JD
Immunogenetics; 1989; 30(1):27-33. PubMed ID: 2568334
[TBL] [Abstract][Full Text] [Related]
11. A study of the association of HLA DR, DQ, and complement C4 alleles with systemic lupus erythematosus in Iceland.
Steinsson K; Jónsdóttir S; Arason GJ; Kristjánsdóttir H; Fossdal R; Skaftadóttir I; Arnason A
Ann Rheum Dis; 1998 Aug; 57(8):503-5. PubMed ID: 9797559
[TBL] [Abstract][Full Text] [Related]
12. C4 complement allotypes in juvenile dermatomyositis.
Robb SA; Fielder AH; Saunders CE; Davey NJ; Burley MW; Lord DH; Batchelor JR; Dubowitz V
Hum Immunol; 1988 May; 22(1):31-8. PubMed ID: 3260584
[TBL] [Abstract][Full Text] [Related]
13. MHC-extended haplotypes in families of patients with Graves' disease.
Ratanachaiyavong S; Lloyd L; Darke C; McGregor AM
Hum Immunol; 1993 Feb; 36(2):99-111. PubMed ID: 8096501
[TBL] [Abstract][Full Text] [Related]
14. Human C4 polymorphism: pedigree analysis of qualitative, quantitative, and functional parameters as a basis for phenotype interpretations.
Mauff G; Bender K; Giles CM; Goldmann S; Opferkuch W; Wachauf B
Hum Genet; 1984; 65(4):362-72. PubMed ID: 6420328
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 70 (HSP70) and complement C4 genotypes in patients with hyperthyroid Graves' disease.
Ratanachaiyavong S; Demaine AG; Campbell RD; McGregor AM
Clin Exp Immunol; 1991 Apr; 84(1):48-52. PubMed ID: 1673096
[TBL] [Abstract][Full Text] [Related]
16. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
[TBL] [Abstract][Full Text] [Related]
17. Early-onset autoimmune hepatitis is associated with a C4A gene deletion.
Scully LJ; Toze C; Sengar DP; Goldstein R
Gastroenterology; 1993 May; 104(5):1478-84. PubMed ID: 8482459
[TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo.
Venneker GT; Westerhof W; de Vries IJ; Drayer NM; Wolthers BG; de Waal LP; Bos JD; Asghar SS
J Invest Dermatol; 1992 Dec; 99(6):853-8. PubMed ID: 1469300
[TBL] [Abstract][Full Text] [Related]
19. Combined heterozygous deficiency of the classical complement pathway proteins C2 and C4.
Hartmann D; Fremeaux-Bacchi V; Weiss L; Meyer A; Blouin J; Hauptmann G; Kazatchkine M; Uring-Lambert B
J Clin Immunol; 1997 Mar; 17(2):176-84. PubMed ID: 9083894
[TBL] [Abstract][Full Text] [Related]
20. Long PCR detection of the C4A null allele in B8-C4AQ0-C4B1-DR3.
Grant SF; Kristjánsdóttir H; Steinsson K; Blöndal T; Yuryev A; Stefansson K; Gulcher JR
J Immunol Methods; 2000 Oct; 244(1-2):41-7. PubMed ID: 11033017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
